TILBURG, the Netherlands, March 15, 2016 /PRNewswire/ --
Frameless, multisession Gamma Knife radiosurgery a new option at Tilburg hospital
On January 11, the Gamma Knife Center at Elisabeth Tweesteden Ziekenhuis (ETZ, Tilburg) launched a new frameless option for its advanced cranial radiosurgery program with the treatment of a 74-year-old male patient with a large, recurrent vestibular schwannoma, a slow-growing tumor of the inner ear. Using its new Leksell Gamma Knife® Icon™ system, clinicians used a frameless (mask-based) approach to immobilize the patient's head and deliver the therapy over multiple sessions (fractions).
Gamma Knife Icon is the latest advance in Elekta's industry-leading stereotactic radiosurgery (SRS) technology, delivering industry-leading accuracy and the lowest dose to normal tissue. With the option to use frameless or traditional frame-based treatments, Icon offers greatly enhanced flexibility in how clinicians deliver stereotactic radiosurgery. Frameless therapy provides the opportunity to treat patients with large or critically located lesions over several sessions, thereby expanding the range of patients who could benefit from Gamma Knife radiosurgery.
"The patient's tumor was 21.5 cm in volume, which was too large to treat in single session," says Guus Beute, MD, ETZ neurosurgeon. With the Icon system's frameless head immobilization we were able to divide the therapy into five treatments and be assured of precise repositioning for each session."
To date, ETZ has treated 146 patients on Icon using frame-based immobilization, in addition to two more patients who received multisession, frameless treatments. One of these, a female patient with 11 meningiomas, received "staged" therapy in which six lesions were treated in one session and five in a second session.
"We could have treated her in one two-hour session with the frame, but we recommended that she have a frameless treatment and stage the therapy in two shorter sessions," Dr. Beute notes. "It was more convenient and comfortable for the patient, so we were pleased we could offer her that as an option."
Precise repositioning critical for multisession therapy
Multisession, frameless radiosurgery demands management of differences in the patient's repositioning from session to session. The cone beam CT (CBCT) imaging technology and advances in Gamma Knife treatment planning system enables automatic online adaptation of the dose delivery to correct for patient repositioning differences session to session.
"The ability to accurately reposition the patient with Icon gives us a lot of confidence, and offers a very smooth and quick workflow," he says. "Leksell GammaPlan® software automatically adapts the plan if there are any changes in patient position. These are usually so small that the corrected plan looks identical to the original plan. We simply review and accept the corrected plan and then treat."
Another Icon safety innovation is the high-definition motion management (HDMM) system, which monitor's the patient's head during treatment via infrared tracking of a marker on the nose. If movement exceeds a certain threshold set by the physician (1-1.5 mm at ETZ), treatment stops.
For the three frameless treatments we've done so far, we were pleased to see that the motion management system did not activate," Dr. Beute recalls. "That tells me that patient immobilization is very secure."
Dr. Beute anticipates performing 40-60 frameless treatments in the first year with Icon, in addition to the usual 650 frame-based Gamma Knife radiosurgeries. ETZ has been using Gamma Knife technology since 2002.
Together with his colleague Dr. Patrick Hanssens, Dr. Beute will serve as co-chairman of the 18th Leksell Gamma Knife Society meeting, which convenes in Amsterdam May 15-19. The scientific program will focus on interactive presentations moderated by experts in the field of radiosurgery and other relevant medical fields. The meeting is expected to draw 500 participants from 40 countries and a record number of abstracts.
To learn more about Leksell Gamma Knife Icon, visit http://www.careforthebrain.com.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: http://www.elekta.com.
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31-653-561-242, e-mail: firstname.lastname@example.org
Time zone: CET: Central European Time
Raven Canzeri, Global Public Relations Manager, Elekta
Tel: +1-770-670-2524, e-mail: email@example.com
Time zone: ET: Eastern Time